Beijing Inno Medicine clinical trials
Beijing Inno Medicine is the lead sponsor of 3 current clinical trials in our China, USA, Canada and Australia registers. 3 are recruiting patients now. The most common phase is Phase 2. The most-studied condition is Glioma.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Beijing Inno Medicine
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
NCT07521007 · Atherosclerosis, Coronary Artery Disease
|
Phase 2 | Recruiting | 2026-07 | USA, China, Canada, Australia |
|
A Phase I Clinical Study of YN003 in the Treatment of Glioma
NCT07929909 · ClinicalTrials.gov ↗ · Glioma, Glioblastoma, Brain Neoplasms
|
Phase 1 | Recruiting | 2026-10 | USA, China |
|
Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction
NCT07311330 · ClinicalTrials.gov ↗ · Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction
|
Phase 2 | Recruiting | 2026-02 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Beijing Inno Medicine trials
7 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 3 | 3 |
| Clinical trials in USA | 2 | 2 |
| Clinical trials in Canada | 1 | 1 |
| Clinical trials in Australia | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Glioma
Sponsors with the most current trials registered for this condition.
Questions about Beijing Inno Medicine trials
How many clinical trials does Beijing Inno Medicine sponsor?
Beijing Inno Medicine is the lead sponsor of 3 current trials on ClinicalTrials.gov in our China, USA, Canada and Australia registers, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are Beijing Inno Medicine trials recruiting?
Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.